Verification of the Use of Derivative Financial Instruments in Sponsor Due Diligence

The SFC’s 2025 thematic inspection of IPO sponsors revealed that verification of derivative financial instruments remains a persistent deficiency area, with 68% of reviewed prospectuses containing at least one material misstatement or omission related to derivative positions, according to the SFC’s Report on Thematic Inspection of Sponsor Due Diligence on Financial Instruments (March 2025). This finding is not a new regulatory shock—the SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (SFC Code, para. 17.6) has long required sponsors to “take reasonable steps to ensure that the information contained in the listing document is accurate and complete in all material respects.” Yet the 2025 data shows that derivative verification—across FX forwards, commodity swaps, interest rate caps, and embedded structured products—is systematically under-resourced and procedurally inconsistent. The consequence is direct: the SFC has issued three formal disciplinary actions against sponsors in 2024-2025 specifically for failures in derivative due diligence, with fines ranging from HKD 8 million to HKD 25 million per case (SFC Enforcement News, December 2024). For sponsors holding a Type 6 (Advising on Corporate Finance) licence, this is not a theoretical compliance gap—it is an active enforcement risk that directly threatens licensing conditions under the Securities and Futures Ordinance (Cap. 571, s. 194). The following analysis provides a structured, rule-based framework for verifying derivative financial instruments during sponsor due diligence, grounded in SFC guidance, HKEX Listing Rules, and market practice.

The Regulatory Basis for Derivative Verification

SFC Code of Conduct and the Sponsor’s Duty

The SFC’s Code of Conduct (para. 17.6) establishes the sponsor’s overarching duty to exercise “due skill, care and diligence” in verifying all material information in a listing document. Derivative financial instruments are explicitly captured under this duty because their valuation is inherently complex, often involves significant management judgment, and directly impacts the issuer’s financial position, risk profile, and earnings volatility. The SFC’s 2025 thematic inspection report cited paragraphs 17.6(b) and 17.6(d) of the Code as the primary basis for finding sponsor failures: sponsors had not independently verified counterparty confirmations, had accepted management-prepared fair value estimates without independent re-computation, and had failed to reconcile derivative notional amounts against the issuer’s business operations.

HKEX Listing Rule 11.07 (Main Board) requires that a listing document contain “all information necessary to enable an investor to make an informed assessment of the activities, assets and liabilities, financial position, management and prospects of the issuer.” Where derivative instruments constitute a material asset or liability—typically defined as exceeding 5% of total assets or 10% of net profit before tax—the sponsor must verify the existence, valuation, and economic substance of each position. The 2025 SFC data showed that 42% of deficiencies involved derivatives that had been classified as immaterial by the sponsor but later proved material when the issuer’s underlying exposure was correctly aggregated.

The Three-Pillar Verification Framework

The SFC’s Guidance Note on Due Diligence by Sponsors in Respect of Listing Applications (December 2024 update) introduces a three-pillar framework specifically for financial instruments: (1) existence and ownership, (2) valuation and fair value measurement, and (3) economic substance and business rationale. Each pillar carries distinct verification procedures that must be documented in the sponsor’s working papers under the SFC’s Guidelines on Sponsor Working Papers (para. 4.2). The 2025 inspection found that only 23% of sponsors had working papers that addressed all three pillars for derivative positions; the remainder had documented only one or two pillars, typically existence and valuation, while omitting economic substance entirely.

Verification Pillar 1: Existence and Ownership

Counterparty Confirmation and Third-Party Verification

The primary evidence for derivative existence is the counterparty confirmation, typically issued by the bank or financial institution that is the counterparty to the derivative contract. The SFC’s 2025 inspection report specifically criticised sponsors for accepting confirmations that were not independently verified: in 31% of reviewed cases, the sponsor relied on confirmations provided directly by the issuer’s finance department rather than requesting them directly from the counterparty. The correct procedure under the SFC Code (para. 17.6(b)) requires the sponsor to obtain confirmations directly from the counterparty’s authorised signatory, preferably through a secure electronic channel or by physical mail to the sponsor’s office, not to the issuer.

Where the derivative is traded on an exchange—such as HKEX’s stock futures or the Hong Kong Futures Exchange’s commodity contracts—the sponsor should obtain a direct statement from the clearing house (e.g., HKCC or OTC Clear) or the broker’s custody statement. For OTC derivatives, the International Swaps and Derivatives Association (ISDA) master agreement and the credit support annex (CSA) must be reviewed to confirm the legal enforceability of the contract and the collateral arrangements. The SFC’s 2024 Enforcement Bulletin (No. 15) noted that two sponsor failures involved derivatives governed by ISDA agreements where the sponsor had not verified that the counterparty was a licensed institution under the Banking Ordinance (Cap. 155) or a registered entity under the SFC’s Securities and Futures (Financial Resources) Rules (Cap. 571N).

Reconciliation to the Issuer’s General Ledger and Trial Balance

Existence verification must extend beyond the counterparty confirmation to a reconciliation of the derivative positions against the issuer’s general ledger, trial balance, and management accounts. The sponsor should obtain the issuer’s derivative sub-ledger, which records each position by counterparty, notional amount, trade date, maturity date, and mark-to-market value. The reconciliation should identify any positions recorded in the ledger but not confirmed by the counterparty, and vice versa. The 2025 SFC inspection found that 27% of deficiency cases involved derivatives that appeared in the counterparty confirmation but were not recorded in the issuer’s ledger—a red flag for potential off-balance-sheet exposure or undisclosed financing arrangements.

For issuers with multiple subsidiaries, particularly those incorporated in the BVI, Cayman Islands, or Bermuda as holding companies, the sponsor must confirm that each derivative is recorded in the legal entity that is the actual counterparty. The SFC’s Guidance Note (December 2024) specifically warns against “aggregation errors” where derivatives held by a non-material subsidiary are excluded from the sponsor’s verification scope, only to become material when the subsidiary’s exposure is consolidated at the group level. The sponsor should obtain a legal entity structure chart and map each derivative position to the relevant subsidiary’s general ledger.

Verification Pillar 2: Valuation and Fair Value Measurement

Independent Re-Computation of Fair Value

The SFC’s 2025 thematic inspection found that 58% of sponsor failures related to derivative valuation involved the sponsor accepting management’s fair value estimate without independent re-computation. Under the SFC Code (para. 17.6(d)), the sponsor must perform its own calculation of the derivative’s fair value, using observable market inputs where available. For plain-vanilla derivatives—such as FX forwards, interest rate swaps, and commodity futures—the sponsor can use standard pricing models (e.g., Black-Scholes for options, discounted cash flow for swaps) with market data obtained from Bloomberg, Reuters, or the issuer’s counterparty.

The sponsor must document the valuation methodology, the source of each input parameter (e.g., the yield curve for discounting, the volatility surface for options), and the calculation itself. The working papers should include a sensitivity analysis showing how a 10% change in each key input would affect the fair value, as required by the SFC’s Guidelines on Sponsor Working Papers (para. 5.3). The 2025 inspection found that only 19% of sponsors had performed any sensitivity analysis on derivative valuations; the remainder had simply accepted management’s single-point estimate.

Classification of Valuation Hierarchy

Under HKFRS 9 Financial Instruments (paragraph 4.1-4.5), derivatives must be classified as fair value through profit or loss (FVTPL) unless they qualify for hedge accounting. The sponsor must verify that the issuer’s classification is correct, particularly where the issuer has designated derivatives as hedging instruments under HKFRS 9 (paragraph 6.2-6.7). The sponsor should review the hedge documentation, including the risk management objective, the hedging relationship, and the effectiveness testing methodology. The SFC’s 2025 report identified 14 cases where issuers had classified derivatives as cash flow hedges but had not performed the required effectiveness testing—a misstatement that directly affects the profit and loss statement.

Where the derivative is classified as Level 3 under HKFRS 13 Fair Value Measurement (paragraph 86-89)—meaning valuation relies on unobservable inputs—the sponsor must perform additional procedures. The SFC’s Guidance Note (December 2024) requires the sponsor to engage an independent valuer, typically a Big Four accounting firm or a specialist valuation boutique, to provide a second opinion on the fair value. The sponsor must also disclose the valuation methodology and the key unobservable inputs in the prospectus, as required by HKEX Listing Rule 11.07 and the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32, s. 38B). The 2025 inspection found that 37% of Level 3 derivative valuations in reviewed prospectuses lacked the required disclosure.

Verification Pillar 3: Economic Substance and Business Rationale

Linkage to the Issuer’s Business Operations

The SFC’s 2025 thematic inspection emphasised that derivative due diligence cannot stop at existence and valuation; the sponsor must verify the economic substance of each derivative position—specifically, whether the derivative serves a genuine hedging, financing, or investment purpose that is consistent with the issuer’s disclosed business model. The SFC’s Code of Conduct (para. 17.6(b)) requires the sponsor to obtain an understanding of the issuer’s risk management policies and to assess whether each derivative transaction is consistent with those policies.

For an issuer in the commodities trading sector, for example, a commodity swap to fix the price of a raw material input is consistent with hedging. A similar swap on a commodity that the issuer does not purchase or sell, however, is speculative and must be disclosed as such. The 2025 inspection report cited 22 cases where issuers had classified speculative derivatives as hedging instruments in the prospectus, misleading investors about the issuer’s risk profile. The sponsor must obtain the issuer’s board-approved risk management policy, the minutes of the board or treasury committee meeting that approved each derivative transaction, and the underlying commercial contract (e.g., the purchase order or sales agreement) that the derivative is intended to hedge.

Identification of Embedded Derivatives and Structured Products

The SFC’s 2025 report specifically highlighted embedded derivatives—derivatives that are embedded in non-derivative host contracts, such as convertible bonds, preference shares with conversion features, or lease agreements with variable payments linked to an index. Under HKFRS 9 (paragraph 4.3.3), an embedded derivative must be separated from the host contract and accounted for separately at fair value if the economic characteristics and risks of the embedded derivative are not closely related to the host contract. The sponsor must review the issuer’s analysis of each embedded derivative and verify the separation decision.

The 2025 inspection found that 31% of reviewed prospectuses contained at least one embedded derivative that had not been identified by the sponsor. Common examples included convertible bonds issued by PRC companies with a conversion price linked to the issuer’s share price on the Hong Kong Stock Exchange—where the conversion feature is an embedded equity derivative—and preference shares with a mandatory conversion into a variable number of ordinary shares, which is an embedded derivative liability under HKFRS 9 (paragraph 4.3.5). The sponsor must obtain the legal documentation for each host contract, identify any embedded features, and assess whether separation is required.

For structured products—such as principal-protected notes, equity-linked notes, or credit-linked notes—the sponsor must analyse the product’s payoff structure to determine whether it contains one or more embedded derivatives. The SFC’s Guidance Note (December 2024) requires the sponsor to obtain the term sheet, the product prospectus, and the valuation model from the issuer or the product arranger. The sponsor must then verify that the issuer’s accounting treatment is consistent with the product’s economic substance, not merely its legal form. The 2025 inspection identified 18 cases where structured products had been classified as debt instruments at amortised cost when their derivative components should have required fair value accounting.

Practical Implementation and Documentation Standards

Working Paper Requirements for Derivative Verification

The SFC’s Guidelines on Sponsor Working Papers (para. 4.2) require that the sponsor’s working papers contain “sufficient detail to enable a reviewer to understand the nature, timing, and extent of the due diligence procedures performed.” For derivative verification, this means the working papers must include, at a minimum: (1) a schedule of all derivative positions, with counterparty, notional amount, maturity, and fair value; (2) copies of counterparty confirmations obtained directly by the sponsor; (3) the sponsor’s independent fair value calculation, with all input parameters documented; (4) the issuer’s hedge documentation and effectiveness testing; (5) the legal documentation for any embedded derivatives or structured products; and (6) the sponsor’s assessment of economic substance, including board minutes and underlying commercial contracts.

The 2025 SFC inspection found that 73% of sponsors had working papers that did not contain all six elements for derivative positions. The most common omission was the independent fair value calculation (missing in 58% of cases), followed by the economic substance assessment (missing in 47% of cases). The SFC has made clear that incomplete working papers constitute a breach of the SFC Code (para. 17.6) and can result in disciplinary action, including fines and licence conditions.

Engagement of Third-Party Experts

Where the derivatives are complex—such as exotic options, structured credit derivatives, or bespoke OTC instruments—the sponsor should consider engaging a third-party expert, typically a valuation firm or a quantitative advisory team, to provide an independent assessment. The SFC’s Guidance Note (December 2024) states that the sponsor “should not rely solely on management’s valuation or on the counterparty’s valuation without independent verification.” The expert’s report should be included in the sponsor’s working papers, and the sponsor must document its own assessment of the expert’s qualifications, methodology, and conclusions.

The cost of engaging a third-party expert for derivative verification is typically HKD 200,000 to HKD 800,000 per engagement, depending on the number and complexity of positions. This cost is material for a sponsor’s budget but is negligible compared to the potential fine of HKD 8 million to HKD 25 million for a failed verification. The 2025 inspection data supports this: sponsors that engaged third-party experts for derivative verification had a deficiency rate of 12%, compared to 68% for sponsors that relied solely on internal resources.

Actionable Takeaways

1. Implement a three-pillar verification framework for all derivative positions, covering existence and ownership, valuation and fair value measurement, and economic substance and business rationale, with each pillar documented in the sponsor’s working papers under the SFC’s Guidelines on Sponsor Working Papers (para. 4.2).

2. Obtain counterparty confirmations directly from the counterparty’s authorised signatory, not through the issuer, and reconcile each position against the issuer’s general ledger, trial balance, and legal entity structure chart.

3. Perform an independent fair value re-computation for every derivative position, using observable market inputs from Bloomberg or Reuters, and include a sensitivity analysis for each key input parameter.

4. Identify all embedded derivatives in convertible bonds, preference shares, structured products, and other host contracts, and verify the issuer’s separation decision under HKFRS 9 (paragraph 4.3.3).

5. Engage a third-party expert for any derivative classified as Level 3 under HKFRS 13, or for any exotic or bespoke OTC instrument, and include the expert’s report in the sponsor’s working papers.